CAUSEY CHRISTOPHER sold UTHR
March 30, 2026 · Form 4 insider transaction
CAUSEY CHRISTOPHER sold 1,300 shares of United Therapeutics Corporation at $604.64 per share, a transaction worth $786.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,300
Price
$604.64
Total value
$786.0K
InsiderCAUSEY CHRISTOPHER
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 30, 2026
Filing dateMarch 31, 2026
Shares owned after4,190
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025.